Epitopes described in "Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy."

Reference
Article Authors:Christian Siebold; Bjarke E Hansen; Jessica R Wyer; Karl Harlos; Robert E Esnouf; Arne Svejgaard; John I Bell; Jack L Strominger; E Yvonne Jones; Lars Fugger
Article Title:Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy.
Reference Detail
Reference ID:725
Abstract:The MHC class II molecule DQ0602 confers strong susceptibility to narcolepsy but dominant protection against type 1 diabetes. The crystal structure of DQ0602 reveals the molecular features underlying these contrasting genetic properties. Structural comparisons to homologous DQ molecules with differential disease associations highlight a previously unrecognized interplay between the volume of the P6 pocket and the specificity of the P9 pocket, which implies that presentation of an expanded peptide repertoire is critical for dominant protection against type 1 diabetes. In narcolepsy, the volume of the P4 pocket appears central to the susceptibility, suggesting that the presentation of a specific peptide population plays a major role.
Date:2004
Reference Type:Literature
PubMed ID:14769912
Journal:Proc Natl Acad Sci U S A
Journal Volume:101
Article Pages:1999-2004
Journal ISSN:1091-6490
Article Chemical List:HLA-DQ Antigens;HLA-DQ beta-Chains;HLA-DQB1 antigen;Membrane Glycoproteins
Article MeSH List:Alleles; Amino Acid Sequence; Binding Sites; Crystallography, X-Ray; Diabetes Mellitus, Type 1(genetics); Genetic Predisposition to Disease; HLA-DQ Antigens(chemistry; genetics); HLA-DQ beta-Chains; Humans; Membrane Glycoproteins; Models, Molecular; Narcolepsy(genetics); Polymorphism, Genetic(genetics); Protein Binding; Protein Conformation; Structure-Activity Relationship
Curation Last Updated:2014-04-01 17:59:12